| Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment G Baskol, H Atmaca, F Tanrıverdi, M Baskol, D Kocer, F Bayram Experimental and Clinical Endocrinology & Diabetes 115 (08), 522-526, 2007 | 214 | 2007 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 178 | 2021 |
| Prevalence of dyslipidemia and associated risk factors in Turkish adults F Bayram, D Kocer, K Gundogan, A Kaya, O Demir, R Coskun, T Sabuncu, ... Journal of clinical lipidology 8 (2), 206-216, 2014 | 170 | 2014 |
| Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia K Gündogan, F Bayram, M Capak, F Tanriverdi, A Karaman, A Ozturk, ... Metabolic syndrome and related disorders 7 (5), 427-434, 2009 | 159 | 2009 |
| The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome K Ünlühizarci, F Keleştimur, F Bayram, Y Şahin, A Tutuş Clinical Endocrinology 51 (2), 231-236, 1999 | 153 | 1999 |
| CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries O Mosenzon, A Alguwaihes, JLA Leon, F Bayram, P Darmon, TME Davis, ... Cardiovascular Diabetology 20, 1-13, 2021 | 152 | 2021 |
| Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults K Gundogan, F Bayram, V Gedik, A Kaya, A Karaman, Ö Demir, ... Archives of Medical Science 9 (2), 243-253, 2013 | 149 | 2013 |
| A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting M Cesur, D Corapcioglu, A Gursoy, S Gonen, M Ozduman, R Emral, ... Diabetes research and clinical practice 75 (2), 141-147, 2007 | 130 | 2007 |
| Effects of antidepressant treatment and of gender on serum leptin levels in patients with major depression E Esel, S Ozsoy, A Tutus, S Sofuoglu, S Kartalci, F Bayram, Z Kokbudak, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 (4), 565-570, 2005 | 117 | 2005 |
| A comparison between the 1-μg adrenocorticotropin (ACTH) test, the short ACTH (250 μg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal … HS Dökmetaş, R Çolak, F Keleştimur, A Selçuklu, ... The Journal of Clinical Endocrinology & Metabolism 85 (10), 3713-3719, 2000 | 110 | 2000 |
| Brown tumor of the maxilla associated with primary hyperparathyroidism E Guney, OG Yigitbasi, F Bayram, V Ozer, Ö Canoz Auris Nasus Larynx 28 (4), 369-372, 2001 | 99 | 2001 |
| Endocrine changes in patients with acute organophosphate poisoning M Güven, F Bayram, K Ünlühizarci, F Kelestimur Human & experimental toxicology 18 (10), 598-601, 1999 | 96 | 1999 |
| Evaluation of chromosomal damage, cytostasis, cytotoxicity, oxidative DNA damage and their association with body-mass index in obese subjects H Donmez-Altuntas, F Sahin, F Bayram, N Bitgen, M Mert, K Guclu, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 771, 30-36, 2014 | 84 | 2014 |
| A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism II Müderris, F Bayram, M Güven Fertility and sterility 73 (5), 984-987, 2000 | 84 | 2000 |
| May the neutrophil/lymphocyte ratio be a predictor in the differentiation of different thyroid disorders? D Kocer, Ç KARAKÜKCÜ, H Karaman, F Gokay, F Bayram Asian pacific journal of cancer prevention 16 (9), 2015 | 81 | 2015 |
| Effect of thyroid hormone replacement therapy on ovarian volume and androgen hormones in patients with untreated primary hypothyroidism II Muderris, A Boztosun, G Oner, F Bayram Annals of Saudi medicine 31 (2), 145-151, 2011 | 80 | 2011 |
| Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism F Bayram, II Müderris, M Güven, F Keleştimur European journal of endocrinology 147 (4), 467-471, 2002 | 80 | 2002 |
| The investigation of insulin resistance in patients with idiopathic hirsutism K Ünlühizarci, Y Karababa, F Bayram, F Kelestimur The Journal of Clinical Endocrinology & Metabolism 89 (6), 2741-2744, 2004 | 79 | 2004 |
| Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day) II Müderris, F Bayram, M Güven Gynecological endocrinology 14 (1), 38-41, 2000 | 78 | 2000 |
| A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism İI Müderris, F Bayram, Y Şahin, F Kelestimur Fertility and sterility 68 (4), 644-647, 1997 | 77 | 1997 |
